Suppr超能文献

二极管激光光凝治疗对早产儿视网膜病变患儿眼部生物测量参数的影响

Effects of diode laser photocoagulation treatment on ocular biometric parameters in premature infants with retinopathy of prematurity.

作者信息

Acar Damla Erginturk, Acar Ugur, Tunay Zuhal Ozen, Arman Aysegul, Barak Anil

机构信息

Minister of Health Ankara City Hospital, Ankara 06800, Turkey.

Selcuk University Faculty of Medicine, Konya 42250, Turkey.

出版信息

Int J Ophthalmol. 2021 Feb 18;14(2):277-282. doi: 10.18240/ijo.2021.02.15. eCollection 2021.

Abstract

AIM

To investigate the effects of diode laser treatment on ocular biometric parameters in premature infants with retinopathy of prematurity (ROP).

METHODS

Premature infants who received diode laser treatment for ROP (=68) and premature infants with spontaneous regressed ROP without treatment (=50) were performed longitudinal ocular biometric measurements including anterior chamber depth, lens thickness and axial length as follows: 1d prior to laser treatment, and 3, 6, 9, and 12mo after the laser treatment.

RESULTS

The mean birth weight, gestational age and initial examination time values were 936.53±302.07 g, 26.66±2.42wk, 36.26±2.73wk in the treatment group and 959.78±260.08 g, 27.28±2.10wk, 36.56±2.54wk in the control group. There was no statistically significant difference in these demographic characteristics of the groups. Anterior chamber depth, lens thickness and axial length demonstrated statistically significant linear increases during the study period in the two groups (<0.001 for each). There were no statistically significant differences between the two groups in terms of anterior chamber depth after laser treatment. Measurements of the lens thickness at 9 and 12 months (9 month 3.70±0.22 3.60±0.21 mm, =0.017; 12 month 3.81±0.21 3.69±0.22 mm, =0.002) and the axial length at 12 month (19.35±0.79 19.13±0.54 mm, =0.031) after laser treatment were statistically higher in the treatment group.

CONCLUSION

Diode laser retinal photocoagulation treatment in premature infants seems to increase the lens thickness and axial length.

摘要

目的

探讨二极管激光治疗对早产儿视网膜病变(ROP)患儿眼部生物测量参数的影响。

方法

对接受二极管激光治疗ROP的早产儿(=68例)和未经治疗而ROP自然消退的早产儿(=50例)进行眼部生物测量参数的纵向测量,包括前房深度、晶状体厚度和眼轴长度,测量时间如下:激光治疗前1天,以及激光治疗后3、6、9和12个月。

结果

治疗组的平均出生体重、胎龄和初次检查时间值分别为936.53±302.07g、26.66±2.42周、36.26±2.73周,对照组分别为959.78±260.08g、27.28±2.10周、36.56±2.54周。两组的这些人口统计学特征无统计学显著差异。在研究期间,两组的前房深度、晶状体厚度和眼轴长度均呈统计学显著的线性增加(每项均<0.001)。激光治疗后两组在前房深度方面无统计学显著差异。治疗组激光治疗后9个月和12个月的晶状体厚度测量值(9个月 3.70±0.22对3.60±0.21mm,P=0.017;12个月 3.81±0.21对3.69±0.22mm,P=0.002)以及12个月的眼轴长度测量值(19.35±0.79对19.13±0.54mm,P=0.031)在统计学上更高。

结论

早产儿二极管激光视网膜光凝治疗似乎会增加晶状体厚度和眼轴长度。

相似文献

1
Effects of diode laser photocoagulation treatment on ocular biometric parameters in premature infants with retinopathy of prematurity.
Int J Ophthalmol. 2021 Feb 18;14(2):277-282. doi: 10.18240/ijo.2021.02.15. eCollection 2021.
5
Evaluation of Refractive Errors and Ocular Biometric Outcomes after Intravitreal Bevacizumab for Retinopathy of Prematurity.
Strabismus. 2016 Jun;24(2):84-8. doi: 10.3109/09273972.2016.1159232. Epub 2016 Apr 27.
8
Bedside Diode Laser Photocoagulation Under Remifentanil Analgesia for Retinopathy of Prematurity: Early Structural Outcomes.
Turk J Ophthalmol. 2016 Oct;46(5):209-214. doi: 10.4274/tjo.04557. Epub 2016 Oct 17.
9
Long-term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age.
Acta Ophthalmol. 2013 Jun;91(4):e276-82. doi: 10.1111/aos.12053. Epub 2013 Apr 20.

引用本文的文献

1
Safety and therapeutic efficacy of 577 nm yellow solid krypton laser for retinopathy of prematurity; A prospective pilot study.
Indian J Ophthalmol. 2024 Jun 1;72(6):856-859. doi: 10.4103/IJO.IJO_2490_23. Epub 2024 Feb 5.
2
Refractive Status and Biometric Characteristics of Children With Familial Exudative Vitreoretinopathy.
Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):27. doi: 10.1167/iovs.64.13.27.
3
Latest Trends in Retinopathy of Prematurity: Research on Risk Factors, Diagnostic Methods and Therapies.
Int J Gen Med. 2023 Mar 14;16:937-949. doi: 10.2147/IJGM.S401122. eCollection 2023.

本文引用的文献

2
A review of treatment for retinopathy of prematurity.
Expert Rev Ophthalmol. 2019;14(2):73-87. doi: 10.1080/17469899.2019.1596026. Epub 2019 Mar 29.
4
Evaluation of refractive errors in retinopathy of prematurity screening.
Med Glas (Zenica). 2019 Aug 1;16(2). doi: 10.17392/992-19.
5
Causes of childhood low vision and blindness in New Zealand.
Clin Exp Ophthalmol. 2019 Mar;47(2):165-170. doi: 10.1111/ceo.13443. Epub 2019 Jan 4.
6
Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity.
J AAPOS. 2018 Feb;22(1):61-65.e1. doi: 10.1016/j.jaapos.2017.10.006. Epub 2017 Dec 6.
8
Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.
Curr Eye Res. 2017 Mar;42(3):462-469. doi: 10.1080/02713683.2016.1196709. Epub 2016 Jul 15.
9
Evaluation of Refractive Errors and Ocular Biometric Outcomes after Intravitreal Bevacizumab for Retinopathy of Prematurity.
Strabismus. 2016 Jun;24(2):84-8. doi: 10.3109/09273972.2016.1159232. Epub 2016 Apr 27.
10
Refractive errors and refractive development in premature infants.
J Fr Ophtalmol. 2015 Dec;38(10):934-40. doi: 10.1016/j.jfo.2015.07.006. Epub 2015 Nov 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验